These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34068036)

  • 21. Current challenges in bioequivalence, quality, and novel assessment technologies for topical products.
    Yacobi A; Shah VP; Bashaw ED; Benfeldt E; Davit B; Ganes D; Ghosh T; Kanfer I; Kasting GB; Katz L; Lionberger R; Lu GW; Maibach HI; Pershing LK; Rackley RJ; Raw A; Shukla CG; Thakker K; Wagner N; Zovko E; Lane ME
    Pharm Res; 2014 Apr; 31(4):837-46. PubMed ID: 24395404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Global Bioequivalence Harmonisation Initiative (GBHI): Report of the fifth international EUFEPS/AAPS conference.
    Mehta M; Schug B; Blume HH; Beuerle G; Jiang W; Koenig J; Paixao P; Tampal N; Tsang YC; Walstab J; Wedemeyer R; Welink J
    Eur J Pharm Sci; 2023 Nov; 190():106566. PubMed ID: 37591469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative assessment of the switchability of generic products.
    Karalis V; Bialer M; Macheras P
    Eur J Pharm Sci; 2013 Nov; 50(3-4):476-83. PubMed ID: 23981332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Clobetasol Propionate Generics Using Simplified In vitro Bioequivalence Method for Topical Drug Products.
    Soares KCC; de Souza WC; de S Texeira L; da Cunha-Filho MSS; Gelfuso GM; Gratieri T
    Curr Drug Deliv; 2018; 15(7):998-1008. PubMed ID: 29165079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modified Regulatory Pathways to Approve Generic Drugs in the US and a Systematic Review of Their Outcomes.
    Kesselheim AS; Polinski JM; Fulchino LA; Isaman DL; Gagne JJ
    Drugs; 2015 Apr; 75(6):633-50. PubMed ID: 25822610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between rheological properties, in vitro release and in vivo equivalency of topical formulations of diclofenac.
    Pleguezuelos-Villa M; Merino-Sanjuán M; Hernández MJ; Nácher A; Peris D; Hidalgo I; Soler L; Sallan M; Merino V
    Int J Pharm; 2019 Dec; 572():118755. PubMed ID: 31715355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioequivalence Methodologies for Topical Drug Products: In Vitro and Ex Vivo Studies with a Corticosteroid and an Anti-Fungal Drug.
    Leal LB; Cordery SF; Delgado-Charro MB; Bunge AL; Guy RH
    Pharm Res; 2017 Apr; 34(4):730-737. PubMed ID: 28097506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generics and cost-effective prescribing in Belgium: does bioequivalence always translate in therapeutic equivalence?
    Dupont AG; Heller F
    Acta Clin Belg; 2009; 64(5):406-14. PubMed ID: 19999388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reconstructed Human Epidermis: An Alternative Approach for In Vitro Bioequivalence Testing of Topical Products.
    Agonia AS; Palmeira-de-Oliveira A; Cardoso C; Augusto C; Pellevoisin C; Videau C; Dinis-Oliveira RJ; Palmeira-de-Oliveira R
    Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 35893811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial.
    Alloway RR; Vinks AA; Fukuda T; Mizuno T; King EC; Zou Y; Jiang W; Woodle ES; Tremblay S; Klawitter J; Klawitter J; Christians U
    PLoS Med; 2017 Nov; 14(11):e1002428. PubMed ID: 29135993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The bioequivalence of highly variable drugs and drug products.
    Midha KK; Rawson MJ; Hubbard JW
    Int J Clin Pharmacol Ther; 2005 Oct; 43(10):485-98. PubMed ID: 16240706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of point estimates and study power of bioequivalence studies on establishing bioequivalence between generics by adjusted indirect comparisons.
    Gwaza L; Gordon J; Potthast H; Welink J; Leufkens H; Stahl M; García-Arieta A
    Eur J Clin Pharmacol; 2015 Sep; 71(9):1083-9. PubMed ID: 26105964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics-Based Approaches for Bioequivalence Evaluation of Topical Dermatological Drug Products.
    Raney SG; Franz TJ; Lehman PA; Lionberger R; Chen ML
    Clin Pharmacokinet; 2015 Nov; 54(11):1095-106. PubMed ID: 26063051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bioequivalence of dermatological topical medicines:the Brazilian scenario and the challenges for health surveillance].
    Soares KC; Moraes MV; Gelfuso GM; Gratieri T
    Cien Saude Colet; 2015 Nov; 20(11):3599-608. PubMed ID: 26602737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generic products of antiepileptic drugs: a perspective on bioequivalence, bioavailability, and formulation switches using Monte Carlo simulations.
    Karalis V; Macheras P; Bialer M
    CNS Drugs; 2014 Jan; 28(1):69-77. PubMed ID: 24092569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioequivalence of topical clotrimazole formulations: an improved tape stripping method.
    Parfitt NR; Skinner MF; Bon C; Kanfer I
    J Pharm Pharm Sci; 2011; 14(3):347-57. PubMed ID: 21906479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of surfactant on quality and performance attributes of topical semisolids.
    Kumar Sharma P; Panda A; Parajuli S; Badani Prado RM; Kundu S; Repka MA; Ureña-Benavides E; Narasimha Murthy S
    Int J Pharm; 2021 Mar; 596():120210. PubMed ID: 33493596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discussion of EMA Draft Guideline on Quality and Equivalence of Topical Products Based on Comparison of Approved Mometasone Furoate Drugs.
    Eichner A; Mrestani Y; Hukauf M; Wohlrab J
    Dermatol Ther (Heidelb); 2024 Aug; 14(8):2153-2169. PubMed ID: 38997617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality by Design: Development of the Quality Target Product Profile (QTPP) for Semisolid Topical Products.
    Namjoshi S; Dabbaghi M; Roberts MS; Grice JE; Mohammed Y
    Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32210126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanistic Modeling of In Vitro Skin Permeation and Extrapolation to In Vivo for Topically Applied Metronidazole Drug Products Using a Physiologically Based Pharmacokinetic Model.
    Arora S; Clarke J; Tsakalozou E; Ghosh P; Alam K; Grice JE; Roberts MS; Jamei M; Polak S
    Mol Pharm; 2022 Sep; 19(9):3139-3152. PubMed ID: 35969125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.